Phase II study of capecitabine plus oxaliplatin in patients with gastric cancer resistant/intolerable to CDDP (OGSG1403)

Junji Kawata, Naotoshi Sugimoto, Hirokazu Taniguchi, Shugo Ueda, Kohei Murakami, Kazuhiro Nishikawa, Yukinori Kurokawa, Kazumasa Fujitani, Hisato Kawakami, Daisuke Sakai, Toshio Shimokawa, Taroh Satoh Osaka Gastrointestinal Study Group (OGSG) ESMO-GI 2019, Barcelona, Spain,3 – 6 July 2019

Warning: Trying to access array offset on false in /home/grwdev/grwdev.works/public_html/ogsg2026.grwdev.works/wp/wp-content/themes/OGSG/single.php on line 62